-+ 0.00%
-+ 0.00%
-+ 0.00%

Rapport Therapeutics; Chief Development Officer Yeleswaram Krishnaswamy sells 10,115 common shares for $303,000

Reuters·03/26/2026 20:42:21

Please log in to view news